Covered recipient · General Payments record
NATHANIEL L JONES
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology
General Payments · PY2018–2024
$15,663.48
- Reported across 264 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $4,099.99 | 2 |
| Food and Beverage | $2,503.73 | 79 |
| Travel and Lodging | $639.49 | 2 |
| Gift | $14.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| INTUITIVE SURGICAL, INC. | $5,861.53 | 11 |
| Daiichi Sankyo Inc. | $279.72 | 11 |
| GlaxoSmithKline, LLC. | $136.52 | 6 |
| Regeneron Healthcare Solutions, Inc. | $106.66 | 4 |
| EISAI INC. | $104.03 | 6 |
| Janssen Biotech, Inc. | $88.26 | 5 |
| Incyte Corporation | $74.90 | 4 |
| Merck Sharp & Dohme Corporation | $69.93 | 6 |
| Tempus AI, Inc | $63.44 | 4 |
| Exelixis Inc. | $59.63 | 3 |
| BAXTER HEALTHCARE | $55.04 | 3 |
| ABBVIE INC. | $37.86 | 2 |
| PharmaEssentia USA Corporation | $37.03 | 2 |
| GENZYME CORPORATION | $36.51 | 2 |
| SOBI, INC | $33.14 | 2 |
| Acerta Pharma LLC | $30.68 | 2 |
| Apellis Pharmaceuticals, Inc. | $29.57 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.02 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.25 | 1 |
| Mirati Therapeutics, Inc. | $18.63 | 1 |
| Pharmacosmos Therapeutics Inc. | $17.27 | 1 |
| Genmab U.S., Inc. | $16.36 | 1 |
| TAIHO ONCOLOGY, INC. | $15.86 | 1 |
| Genentech USA, Inc. | $15.18 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $14.87 | 1 |
| Blueprint Medicines Corporation | $14.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (84)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.